Main Category: Conferences
Article Date: 15 May 2012 - 8:00 PDT
Patient / Public:
Healthcare Prof:
Understanding and optimizing market access strategies to penetrate the exciting and diverse South Central America
This event will provide participants with both a broad overview and specific detail of the market access, pricing and reimbursement environments in key Latin American countries such as Brazil, Mexico, Argentina, Colombia, Venezuela, Chile, Panama and Costa Rica. A thorough understanding will be achieved by hearing the perspectives of payers, government officials and key opinion leaders from academia, as well as learning from the case-study experiences from pharma industry veterans who have successfully overcome challenges to launch innovative medicines in this exciting region.
Why attend?
- Learn how to demonstrate product value to local HTA agencies, regulators and payers.
- Hear multiple perspectives from all stakeholders such as the pharmaceutical and medical device industries, academia, HTAs, regulators and payers.
- View the potential picture of market growth and market access in Latin America.
- Understand different market approaches and barriers to market access from the industry perspective.
- Understand the market's affordability and willingness to reimburse innovative, high-cost drugs.
- Benchmark, network and co-operate with pharma non-pharma decision makers.
To request the full agenda please follow this link.
For Booking Information contact:
Erika Vavrovicova
Tel: +421 232 660 382
Fax: +421 2 3301 0331
Email: erika@nextlevelpharma.com
https://www.nextlevelpharma.com/events/view/market_patient_access_in_latin_america
Conference Dates: 14-15 August 2012
Venue: Rio de Janeiro, Brazil
- Additional
- References
- Citations
MLA
APA
Please note: If no author information is provided, the source is cited instead.
Add Your Opinion On This Article
'2nd Annual Market Patient Access In Latin America Conference, 14-15 August 2012, Brazil'Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Privacy Policy | Terms and Conditions
MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.
back to top | home | privacy policy
MediLexicon International LtdBexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.
Tidak ada komentar:
Posting Komentar